Search
for
Sort by
Research 151–180 of 1000+
- Clinical Evaluation of Women Presenting with Low Libido and Determination of Whether Androgen Therapy Might Be Appropriate
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- The Intersection of Sleep and Hair Loss: A Systematic Review
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- General Dermatology
- Alopecia Universalis Hair Regrowth with Hormones
- Aldesleukin
- Iatrogenic androgen and estrogen excess in a postmenopausal woman presenting with facial erythema, acne, and hirsutism
- Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
- Hirsutism
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application
- Skin abnormality and hairloss: the reproductive endocrinological viewpoint
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The Rotterdam Study: 2018 update on objectives, design and main results
- The Rotterdam Study: 2016 objectives and design update
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Pathobiology of chemotherapy-induced hair loss
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous complications of chemotherapeutic agents
- Physiologic skin changes in pregnancy
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata